th, never underestimate the greed factor for them to make money an inturn us if we are quick.not doing as much trading so i have more time too spare and thus more commentary on rrs.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%